SwePub
Sök i LIBRIS databas

  Utökad sökning

L773:1473 3099
 

Sökning: L773:1473 3099 > Optimising treatmen...

Optimising treatments for sexually transmitted infections : surveillance, pharmacokinetics and pharmacodynamics, therapeutic strategies, and molecular resistance prediction

Seña, Arlene C. (författare)
Department of Medicine, University of North Carolina, Chapel Hill, NC, USA
Bachmann, Laura (författare)
Department of Medicine, Wake Forest University, Winston Salem, NC, USA; Division of Sexually Transmitted Diseases Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
Johnston, Christine (författare)
Department of Medicine, University of Washington, Seattle, WA, USA
visa fler...
Wi, Teodora (författare)
Global HIV, Hepatitis and Sexually Transmitted Infections Programme, WHO, Geneva, Switzerland
Workowski, Kimberly (författare)
Division of Sexually Transmitted Diseases Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA; Department of Medicine, Emory University, Atlanta, GA, USA
Hook, Edward W., 3rd (författare)
Department of Medicine, University of Alabama, Birmingham, AL, USA
Hocking, Jane S. (författare)
Sexual Health Unit, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia
Drusano, George (författare)
Institute for Therapeutic Innovation, University of Florida, Orlando, FL, USA
Unemo, Magnus, 1970- (författare)
Örebro universitet,Institutionen för medicinska vetenskaper,Region Örebro län,WHO Collaborating Centre for Gonorrhoea and Other Sexually Transmitted Infections and the Swedish Reference Laboratory for STIs, Department of Laboratory Medicine
visa färre...
 (creator_code:org_t)
Elsevier, 2020
2020
Engelska.
Ingår i: The Lancet - Infectious diseases. - : Elsevier. - 1473-3099 .- 1474-4457. ; 20:8, s. e181-e191
  • Forskningsöversikt (refereegranskat)
Abstract Ämnesord
Stäng  
  • Progressive antimicrobial resistance in Neisseria gonorrhoeae, Mycoplasma genitalium, and Trichomonas vaginalis has created a pressing need for treatment optimisations for sexually transmitted infections (STIs). In this Review, we aim to highlight urgent needs in global STI management, including: (1) improved surveillance to monitor antimicrobial resistance and clinical outcomes; (2) systematic pharmacokinetic and pharmacodynamic evaluations to ensure resistance suppression and bacterial eradication at all sites of infection; (3) development of novel, affordable antimicrobials; and (4) advancements in new molecular and point-of-care tests to detect antimicrobial resistance determinants. Antimicrobial resistance among STIs is a global public health crisis. Continuous efforts to develop novel antimicrobials will be essential, in addition to other public health interventions to reduce the global STI burden. Apart from prevention through safer sexual practices, the development of STI vaccines to prevent transmission is a crucial research priority.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Infektionsmedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Infectious Medicine (hsv//eng)

Publikations- och innehållstyp

ref (ämneskategori)
for (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy